Physician profile
Alyson Larson
NPI 1184231177
$1,237.38
in general payments reported to CMS, 2019-2025
15 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $112 · 2023: $283 · 2024: $339 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915 · Education: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $915.23 |
| Education | $210.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $499.05 | 2022-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Janssen Pharmaceuticals, INC | $140.02 | 2022-2025 | Invega Sustenna, Invega Trinza, Invega |
| Neurocrine Biosciences, INC. | $139.41 | 2023-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $115.18 | 2023-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Alkermes, INC. | $102.88 | 2023-2025 | Aristada, Lybalvi, Vivitrol |
| E.R. Squibb & Sons, L.L.C. | $41.79 | 2025 | Cobenfy |
| Lundbeck LLC | $37.29 | 2023 | Vyepti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.50 | 2023-2024 | Caplyta |
| Xeris Pharmaceuticals, INC. | $22.02 | 2024 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $21.43 | 2025 | Trelegy Ellipta |
| Vanda Pharmaceuticals INC. | $20.64 | 2025 | Fanapt |
| Biohaven Pharmaceutical Holding Company LTD. | $18.30 | 2022 | |
| Exact Sciences Corporation | $17.58 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $14.72 | 2025 | Jardiance |
| Agios Pharmaceuticals, INC. | $14.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyson Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.